Arkolith/Insider Trading/ETON/Form 4

Brynjelsen Sean

President & CEO, Director, 10% OwnerEton Pharmaceuticals, Inc. (ETON) · full profile →Form 4 · filed Jun 5, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$3.6M
Net Open-Market Flow
-$3.6M
Transactions
5
5 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 5, 2025Sell(S)70K$16.81$1.2M2.9M
Jun 4, 2025Sell(S)70K$17.00$1.2M2.9M
Jun 3, 2025Sell(S)9K$18.38$159K3.0M
Jun 3, 2025Sell(S)61K$17.38$1.1M3.0M
Jun 3, 2025Sell(S)400$19.02$8K3.0M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-25-019583) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML